Natulan and interstitial lung disease Patient Reports February 09, 2010

Natulan Side Effects Report #4920178-0
Natulan side effect was reported by a Consumer or non-health professional from FRANCE on Feb 14, 2006. Female patient, 56 years of age, was diagnosed with hodgkin's disease  and was treated with Natulan. After drug was administered, patient experienced the following side effects: alveolitis, dermatitis bullous, erythema, hypersensitivity, inflammation, interstitial lung disease, leukopenia, lichenoid keratosis, lung disorder. Natulan dosage: unknown. During the same period patient was treated with ATARAX, ONCOVIN, CIPROFLOXACIN, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Natulan Side Effects Report #4951248-9
Natulan side effect was reported by a Consumer or non-health professional from FRANCE on Mar 14, 2006. Female patient, 56 years of age, was diagnosed with hodgkin's disease  and was treated with Natulan. After drug was administered, patient experienced the following side effects: alveolitis allergic, interstitial lung disease, leukopenia, normochromic normocytic anaemia, renal failure, thrombocytopenia, toxic skin eruption. Natulan dosage: unknown. During the same period patient was treated with ATARAX, ONCOVIN, CIPROFLAXACIN, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Natulan Side Effects Report #4951248-9
Natulan side effect was reported by a Consumer or non-health professional from FRANCE on Mar 14, 2006. Female patient, 56 years of age, was diagnosed with hodgkin's disease  and was treated with Natulan. After drug was administered, patient experienced the following side effects: alveolitis allergic, inflammation, interstitial lung disease, leukopenia, normochromic normocytic anaemia, renal failure, thrombocytopenia, toxic skin eruption. Natulan dosage: unknown. During the same period patient was treated with ATARAX, ONCOVIN, CIFLOX, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Natulan Side Effects Report #4984545-1
Natulan side effect was reported by a Consumer or non-health professional from FRANCE on Apr 12, 2006. Female patient, 56 years of age, was diagnosed with hodgkin's disease  and was treated with Natulan. After drug was administered, patient experienced the following side effects: alveolitis, interstitial lung disease, leukopenia, normochromic normocytic anaemia, pulmonary eosinophilia, respiratory failure, thrombocytopenia, toxic skin eruption. Natulan dosage: unknown. During the same period patient was treated with ATARAX, ONCOVIN, CIPROFLOXACIN, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.